첨단 창상관리 시장 규모, 점유율, 예측 및 동향 분석 : 제품별, 용도별, 최종 사용자별 - 세계 예측(-2031년)

Advanced Wound Care Market Size, Share, Forecast, & Trends Analysis by Product (Dressings [Foam, Film, Hydrogel] NPWT, Hyperbaric Oxygen, Cleanser, Growth Factor, Skin Substitute) Application (Surgical, Trauma, Burn, DFU) End User- Global Forecast to 2031

The advanced wound care market is projected to reach $18.19 billion by 2031 at a CAGR of 6.6% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The rising number of chronic wounds associated with the geriatric population, growing traumatic injuries, rising number of surgeries, benefits offered by the advanced wound care products over the traditional products, technological advancements in wound care management products, and increasing wound care awareness programs are some of the factors driving the growth of this market. However, the high cost of advanced wound care devices and therapies and the availability of alternative treatment options restrain the growth of this market.

Furthermore, therapy-based solutions, rising demand for advanced wound care dressings, and partnerships and collaborations between companies are expected to generate growth opportunities for the players operating in this market. However, the lack of healthcare infrastructure in developing countries is a major challenge impacting market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the advanced wound care market are 3M Company (U.S.), Cardinal Health, Inc. (U.S.), Smith & Nephew plc (U.K.), Integra LifeSciences Corporation (U.S.), Molnlycke Health Care AB (Sweden), Coloplast A/S (Denmark), Convatec Group plc (U.K.), DeRoyal Industries, Inc. (U.S.), Medline Industries, LP (U.S.), B. Braun Melsungen AG (Germany), Organogenesis Inc. (U.S.), Winner Medical Co., Ltd. (China), HARTMANN USA, Inc. (U.S.) MIMEDX Group, Inc. (U.S.), and Mil Laboratories Pvt. Ltd. (India).

Among all the products studied in this report, the active wound care segment is projected to register the highest CAGR of over 9.1% during the forecast period of 2024-2031. Factors such as technological advancements in wound care, rising demand for skin substitutes, and growth factors in wound care are some of the drivers for the growth of this segment.

Among all the applications studied in this report, in 2024, the acute wounds segment is expected to account for the larger share of the advanced wound care market. The large market share of this segment can be attributed to the increasing number of traumatic injuries such as falls, accidents, and burns and the increasing number of surgeries.

Among all the end users studied in this report, in 2024, the hospitals & clinics segment is expected to account for the largest share of the advanced wound care market. The large market share of this segment can be attributed to the growing number of patient visits for wound care and management and surgical procedures in hospitals, the presence of highly skilled healthcare professionals, ease in accessibility, the advancements in wound care, and the adoption of foam dressings, Negative Pressure Wound Therapy (NPWT) devices, sterile saline wound solutions, and skin substitutes by the hospitals & clinics.

An in-depth analysis of the geographical scenario of the advanced wound care market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of over 42.3% of the advanced wound care market. In the region, North America's significant market share can be attributed to several key factors, including the presence of major advanced wound care companies such as 3M Company (U.S.), Cardinal Health, Inc. (U.S.), and HARTMANN USA, Inc. (U.S.); high adoption of advanced wound care devices and products in hospitals & clinics; increasing cases of chronic wounds such as diabetic foot ulcers; and favorable reimbursement policies.

In 2024, the U.S. is expected to account for the largest share of the advanced wound care market in North America. The large share of this regional market is attributed to the presence of major advanced wound care companies, increasing prevalence of chronic wounds, high adoption of advanced wound care products in hospitals & clinics, and growing traumatic injuries.

Scope of the Report:

Advanced Wound Care Market Assessment-by Product

• Advanced Wound Dressings
  • Foam Dressings
• Silicone Foam Dressings
• Non-silicone Foam Dressings
  • Film Dressings
  • Hydrocolloid Dressings
  • Alginate Dressings
  • Collagen Dressings
  • Hydrogel Dressings
  • Super Absorbent Dressings
  • Hydrofiber Dressings
  • Wound Contact Layers
  • Other Advanced Wound Dressings
• Wound Therapy Devices
  • Negative pressure wound therapy (NPWT)/ Vacuum-assisted Closure (VAC)
  • Topical Oxygen Therapy
  • Hyperbaric Oxygen Therapy (HBOT)
  • Pressure Relief Devices
  • Other Wound Therapy Devices
• Wound Care Solutions
  • Sterile Saline Wound Solutions
  • Wound Cleansers
  • Gels
  • Topical Skin Adhesives/Skin Glues
• Active Wound Care
  • Skin Substitutes
  • Growth Factors
• Other Advanced Wound Care Products

Note: Other advanced wound dressings include honey dressings, composite dressings, post-op dressings, surfactant dressings, & synthetic dressings.

Note: Other wound therapy devices include Electromagnetic therapy (EMT), compression therapy, and cleansing & debridement systems.

Note: Other advanced wound care products include wound measurement accessories, skin protectants, rapid dry films, & tapes.

Advanced Wound Care Market Assessment-by Application

• Acute Wounds
  • Surgical Wounds
  • Traumatic Wounds
  • Burns
• Chronic Wounds
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Pressure Ulcers
  • Other Chronic Wounds

Note: Other chronic wounds include arterial ulcers and acute & sub-acute ulcers.

Advanced Wound Care Market Assessment-by End User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Other End Users

Note: Other end users include sports and athletic institutions, defense, and long-term care centers.

Advanced Wound Care Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Switzerland
  • Netherlands
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency and Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection & Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
• 2.3. Market Sizing and Forecasting
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Drivers
  • 4.2.1. Rise in the Number of Chronic Wounds Associated with Geriatric Population
  • 4.2.2. Growing Traumatic Injuries
  • 4.2.3. Rising Number of Surgeries
  • 4.2.4. Benefits Offered by the Advanced Wound Care Products Over the Traditional Products
  • 4.2.5. Technological Advancement in Wound Care Management Products
  • 4.2.6. Increasing Wound Care Awareness Programs
• 4.3. Restraints
  • 4.3.1. High Cost of the Advanced Wound Care Devices and Therapies
  • 4.3.2. Availability of Alternative Treatment Options
• 4.4. Opportunities
  • 4.4.1. Therapy-based Solutions
  • 4.4.2. Rising Demand for the Advanced Wound Care Dressings
  • 4.4.3. Partnerships and Collaborations
• 4.5. Challenges
  • 4.5.1. Lack of Healthcare Infrastructure in Developing Countries
• 4.6. Factor Analysis
• 4.7. Regulatory Analysis
• 4.8. Pricing Analysis
• 4.9. Case Studies
• 4.10. Porter's Five Forces Analysis

5. Advanced Wound Care Market Assessment-by Product

• 5.1. Overview
• 5.2. Advanced Wound Dressings
  • 5.2.1. Foam Dressings
    • 5.2.1.1. Silicone Foam Dressings
    • 5.2.1.2. Non-silicone Foam Dressings
  • 5.2.2. Film Dressings
  • 5.2.3. Hydrocolloid Dressings
  • 5.2.4 Alginate Dressings
  • 5.2.5. Collagen Dressings
  • 5.2.6. Hydrogel Dressings
  • 5.2.7. Super Absorbent Dressings
  • 5.2.8. Hydrofiber Dressings
  • 5.2.9. Wound Contact Layers
  • 5.2.10. Other Advanced Wound Dressings
• 5.3. Wound Therapy Devices
  • 5.3.1. Negative pressure wound therapy (NPWT)/ Vacuum-assisted Closure (VAC)
  • 5.3.2. Topical Oxygen Therapy
  • 5.3.3. Hyperbaric Oxygen Therapy (HBOT)
  • 5.3.4. Pressure Relief Devices
  • 5.3.5. Other Wound Therapy Devices
• 5.4. Wound Care Solutions
  • 5.4.1. Sterile Saline Wound Solutions
  • 5.4.2. Wound Cleansers
  • 5.4.3. Gels
  • 5.4.4. Topical Skin Adhesives/Skin Glues
• 5.5. Active Wound Care
  • 5.5.1. Skin Substitutes
  • 5.5.2. Growth Factors
• 5.6. Other Advanced Wound Care Products

6. Advanced Wound Care Market Assessment-by Application

• 6.1. Overview
• 6.2. Acute Wounds
  • 6.2.1. Surgical Wounds
  • 6.2.2. Traumatic Wounds
  • 6.2.3. Burns
• 6.3. Chronic Wounds
  • 6.3.1. Diabetic Foot Ulcers
  • 6.3.2. Venus Leg Ulcers
  • 6.3.3. Pressure Ulcers
  • 6.3.4. Other Chronic Wounds

7. Advanced Wound Care Market Assessment-by End User

• 7.1. Overview
• 7.2. Hospitals & Clinics
• 7.3. Ambulatory Surgical Centers
• 7.4. Home Care Settings
• 7.5. Other End Users

8. Advanced Wound Care Market Assessment-by Geography

• 8.1. Overview
• 8.2. North America
  • 8.2.1. U.S.
  • 8.2.2. Canada
• 8.3. Europe
  • 8.3.1. Germany
  • 8.3.2. France
  • 8.3.3. U.K.
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Switzerland
  • 8.3.7. Netherlands
  • 8.3.8. Rest of Europe
• 8.4. Asia-Pacific
  • 8.4.1. Japan
  • 8.4.2. China
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. South Korea
  • 8.4.6. Rest of Asia-Pacific
• 8.5. Latin America
  • 8.5.1. Brazil
  • 8.5.2. Mexico
  • 8.5.3. Rest of Latin America
• 8.6. Middle East & Africa

9. Competition Analysis

• 9.1. Overview
• 9.2. Key Growth Strategies
• 9.3. Competitive Benchmarking
• 9.4. Competitive Dashboard
  • 9.4.1. Industry Leaders
  • 9.4.2. Market Differentiators
  • 9.4.3. Vanguards
  • 9.4.4. Emerging Companies
• 9.5. Market Share Analysis/Market Rankings, by Key Players (2023)

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis)

• 10.1. 3M Company
• 10.2. Cardinal Health, Inc.
• 10.3. Smith & Nephew plc
• 10.4. Integra LifeSciences Corporation
• 10.5. Molnlycke Health Care AB
• 10.6. Coloplast A/S
• 10.7. Convatec Group plc
• 10.8. DeRoyal Industries, Inc.
• 10.9. Medline Industries, LP
• 10.10. B. Braun Melsungen AG
• 10.11. Organogenesis Inc.
• 10.12. Winner Medical Co., Ltd.
• 10.13. HARTMANN USA, Inc.
• 10.14. MIMEDX Group, Inc.
• 10.15. Mil Laboratories Pvt. Ltd.

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

11. Appendix

• 11.1. Available Customization
• 11.2. Related Reports